Literature DB >> 31369739

A flexible high content imaging assay for profiling macrophage efferocytosis.

Roger Clark1, Laura Usselmann2, Martin R Brown2, Anne U Goeppert3, Adam Corrigan2.   

Abstract

Macrophages are a diverse population of cells originating from the myeloid lineage, which form an important component of the innate immune system, helping to regulate immune response through secretion of pro/anti-inflammatory cytokines. However they also have an important homeostatic role - helping to remove cellular debris and apoptotic cells from the body (a phagocytic process known as efferocytosis). Here we describe a robust 384 well microplate based imaging assay, using apoptotic target cells for the specific quantification of efferocytosis in human primary monocyte derived macrophages. The methodology described allows for the assay to run in either fixed end-point or live-cell format (the former offering multiple morphological and intensity-based readouts, whilst the latter opens the possibility for future expansion of the methodology to encompass kinetic profiling). Within the methodology described we couple high content image acquisition (on the Cell Voyager 7000S) with multi-parametric image analysis - using Perkin Elmer Columbus combined with GeneData Screener.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD14+; Efferocytosis; High content imaging; Macrophage; MerTK; Multiparametric

Year:  2019        PMID: 31369739     DOI: 10.1016/j.jim.2019.112636

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.

Authors:  Seung-Hyun Bae; Jung-Hoon Kim; Tae Hyun Park; Kyeong Lee; Byung Il Lee; Hyonchol Jang
Journal:  Exp Mol Med       Date:  2022-09-02       Impact factor: 12.153

2.  Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment.

Authors:  Gregory Hamm; Gareth Maglennon; Beth Williamson; Ruth Macdonald; Ann Doherty; Stewart Jones; Jayne Harris; James Blades; Alexander R Harmer; Peter Barton; Philip B Rawlins; Paul Smith; Jon Winter-Holt; Lindsay McMurray; Julia Johansson; Paul Fitzpatrick; William McCoull; Muireann Coen
Journal:  Arch Toxicol       Date:  2022-01-01       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.